Naylor Kyla L, Knoll Gregory A, McArthur Eric, Garg Amit X, Lam Ngan N, Field Bonnie, Getchell Leah E, Hahn Emma, Kim S Joseph
ICES, ON, Canada.
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
Can J Kidney Health Dis. 2021 Jan 21;8:2054358120985376. doi: 10.1177/2054358120985376. eCollection 2021.
The frequency and outcomes of starting maintenance dialysis in the hospital as an inpatient in kidney transplant recipients with graft failure are poorly understood.
To determine the frequency of inpatient dialysis starts in patients with kidney graft failure and examine whether dialysis start status (hospital inpatient vs outpatient setting) is associated with all-cause mortality and kidney re-transplantation.
Population-based cohort study.
We used linked administrative healthcare databases from Ontario, Canada.
We included 1164 patients with kidney graft failure from 1994 to 2016.
All-cause mortality and kidney re-transplantation.
The cumulative incidence function was used to calculate the cumulative incidence of all-cause mortality and kidney re-transplantation, accounting for competing risks. Subdistribution hazard ratios from the Fine and Gray model were used to examine the relationship between inpatient dialysis starts (vs outpatient dialysis start [reference]) and the dependent variables (ie, mortality or re-transplant).
We included 1164 patients with kidney graft failure. More than half (55.8%) of patients with kidney graft failure, initiated dialysis as an inpatient. Compared with outpatient dialysis starters, inpatient dialysis starters had a significantly higher cumulative incidence of mortality and a significantly lower incidence of kidney re-transplantation ( < .001). The 10-year cumulative incidence of mortality was 51.9% (95% confidence interval [CI]: 47.4, 56.9%) (inpatient) and 35.3% (95% CI: 31.1, 40.1%) (outpatient). After adjusting for clinical characteristics, we found inpatient dialysis starters had a significantly increased hazard of mortality in the first year after graft failure (hazard ratio: 2.18 [95% CI: 1.43, 3.33]) but at 1+ years there was no significant difference between groups.
Possibility of residual confounding and unable to determine inpatient dialysis starts that were unavoidable.
In this study we identified that most patients with kidney graft failure had inpatient dialysis starts, which was associated with an increased risk of mortality. Further research is needed to better understand the reasons for an inpatient dialysis start in this patient population.
肾移植受者移植失败后作为住院患者在医院开始维持性透析的频率及结局尚不清楚。
确定肾移植失败患者住院透析开始的频率,并研究透析开始状态(医院住院与门诊环境)是否与全因死亡率和肾脏再次移植相关。
基于人群的队列研究。
我们使用了来自加拿大安大略省的关联行政医疗保健数据库。
我们纳入了1994年至2016年期间1164例肾移植失败患者。
全因死亡率和肾脏再次移植。
使用累积发病率函数计算全因死亡率和肾脏再次移植的累积发病率,并考虑竞争风险。使用Fine和Gray模型的亚分布风险比来研究住院透析开始(与门诊透析开始[对照])与因变量(即死亡率或再次移植)之间的关系。
我们纳入了1164例肾移植失败患者。超过一半(55.8%)的肾移植失败患者作为住院患者开始透析。与门诊透析开始者相比,住院透析开始者的累积死亡率显著更高,肾脏再次移植发生率显著更低(P<0.001)。10年累积死亡率为51.9%(95%置信区间[CI]:47.4,56.9%)(住院患者)和35.3%(95%CI:31.1,40.1%)(门诊患者)。在调整临床特征后,我们发现住院透析开始者在移植失败后的第一年死亡率风险显著增加(风险比:2.18[95%CI:1.43,3.33]),但在1年以上时两组之间无显著差异。
存在残余混杂的可能性,且无法确定不可避免的住院透析开始情况。
在本研究中,我们发现大多数肾移植失败患者开始住院透析,这与死亡风险增加相关。需要进一步研究以更好地了解该患者群体住院透析开始的原因。